Skip to main content

24.04.2024 | Original Paper

Socioeconomic Status and CD4 Count Among People with HIV Who Inject Drugs in St. Petersburg, Russia

verfasst von: Bulat Idrisov, Jenna Van Draanen, Sara Lodi, Karsten Lunze, Simeon D. Kimmel, Emily Kate Quinn, Ve Truong, Elena Blokhina, Natalia Gnatienko, Evgeny Krupitsky, Jeffrey H. Samet, Emily C. Williams

Erschienen in: AIDS and Behavior

Einloggen, um Zugang zu erhalten

Abstract

Lack of access to resources is a “fundamental cause” of poor HIV outcomes across the care cascade globally and may have the greatest impact on groups with co-existing marginalized identities. In a sample of people living with HIV (PWH) who inject drugs and were not on antiretroviral therapy (ART), we explored associations between access to resources and HIV severity. Fundamental Cause Theory (FCT) sees socioeconomic status/access to resources as a root cause of disease and emphasizes that individuals with limited resources have fewer means to mitigate health risks and implement protective behaviors, which ultimately generates disparities in health outcomes. Guided by the FCT, we hypothesized that resource depletion (primary aim) and lower income (secondary aim) were associated with increased HIV severity. Using baseline data from the Linking Infectious and Narcology Care (LINC-II) trial of ART-naive PWH who inject drugs in St. Petersburg, Russia (n = 225), we examined the association between “past year resource runout” (yes vs. no) and “low-income (< 300 USD a month)” and the outcome HIV severity (CD4 count, continuous). We fit two separate linear regression models adjusted for gender, age, time since HIV diagnosis, and prior ART use. Participants had a mean age of 37.5 years and were 60% male. Two thirds (66%) reported resource depletion, and 30% had income below 300 USD a month. Average CD4 count was 416 cells/mm3 (SD 285). No significant association was identified between either resource depletion or low-income and HIV severity (adjusted mean difference in CD4 count for resource depletion: − 4.16, 95% CI − 82.93, 74.62; adjusted mean difference in CD4 count for low-income: 68.13, 95% CI − 15.78, 152.04). Below-average income and running out of resources were common among PWH who inject drugs and are not on ART in St. Petersburg, Russia. Resource depletion and low-income were not significantly associated with HIV disease severity as captured by CD4 count. The nuanced relationship between socioeconomic status and HIV severity among people with HIV who inject drugs and not on ART merits further examination in a larger sample.
Literatur
2.
Zurück zum Zitat Hogg RS, Strathdee SA, Craib KJ, O’Shaughnessy MV, Montaner JS, Schechter M. Lower socioeconomic status and shorter survival following HIV infection. The Lancet. 1994;344(8930):1120–4.CrossRef Hogg RS, Strathdee SA, Craib KJ, O’Shaughnessy MV, Montaner JS, Schechter M. Lower socioeconomic status and shorter survival following HIV infection. The Lancet. 1994;344(8930):1120–4.CrossRef
3.
Zurück zum Zitat Shelton JD, Cassell MM, Adetunji J. Is poverty or wealth at the root of HIV? The Lancet. 2005;366(9491):1057–8.CrossRef Shelton JD, Cassell MM, Adetunji J. Is poverty or wealth at the root of HIV? The Lancet. 2005;366(9491):1057–8.CrossRef
4.
Zurück zum Zitat Fox AM. The HIV-poverty thesis re-examined: poverty, wealth or inequality as a social determinant of HIV infection in sub-Saharan Africa? J Biosoc Sci. 2012;44(4):459–80.CrossRefPubMed Fox AM. The HIV-poverty thesis re-examined: poverty, wealth or inequality as a social determinant of HIV infection in sub-Saharan Africa? J Biosoc Sci. 2012;44(4):459–80.CrossRefPubMed
5.
Zurück zum Zitat Andrus E, Mojola SA, Moran E, Eisenberg M, Zelner J. Has the relationship between wealth and HIV risk in Sub-Saharan Africa changed over time? A temporal, gendered and hierarchical analysis. SSM Popul Health. 2021;29(15): 100833.CrossRef Andrus E, Mojola SA, Moran E, Eisenberg M, Zelner J. Has the relationship between wealth and HIV risk in Sub-Saharan Africa changed over time? A temporal, gendered and hierarchical analysis. SSM Popul Health. 2021;29(15): 100833.CrossRef
7.
Zurück zum Zitat Link BG, Phelan J. Social Conditions As Fundamental Causes of Disease. Journal of Health and Social Behavior. 1995;35:80–94.CrossRef Link BG, Phelan J. Social Conditions As Fundamental Causes of Disease. Journal of Health and Social Behavior. 1995;35:80–94.CrossRef
8.
Zurück zum Zitat Krieger N. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int J Epidemiol. 2001;30(4):668–77.CrossRefPubMed Krieger N. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int J Epidemiol. 2001;30(4):668–77.CrossRefPubMed
9.
Zurück zum Zitat Azmach NN, Hamza TA, Husen AA. Socioeconomic and demographic statuses as determinants of adherence to antiretroviral treatment in HIV infected patients: a systematic review of the literature. Curr HIV Res. 2019;17(3):161–72.CrossRefPubMed Azmach NN, Hamza TA, Husen AA. Socioeconomic and demographic statuses as determinants of adherence to antiretroviral treatment in HIV infected patients: a systematic review of the literature. Curr HIV Res. 2019;17(3):161–72.CrossRefPubMed
10.
Zurück zum Zitat Salleh NA, Van Draanen J, Nosova E, Barrios R, Richardson L. Material security and adherence to antiretroviral therapy (ART) among HIV-positive people who use illicit drugs. AIDS. 2020;34(7):1037–45.CrossRef Salleh NA, Van Draanen J, Nosova E, Barrios R, Richardson L. Material security and adherence to antiretroviral therapy (ART) among HIV-positive people who use illicit drugs. AIDS. 2020;34(7):1037–45.CrossRef
11.
Zurück zum Zitat Jahagirdar D, Walters MK, Novotney A, Brewer ED, Frank TD, Carter A, et al. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019. The Lancet HIV. 2021;8(10):e633-51.CrossRef Jahagirdar D, Walters MK, Novotney A, Brewer ED, Frank TD, Carter A, et al. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019. The Lancet HIV. 2021;8(10):e633-51.CrossRef
14.
Zurück zum Zitat Kirzhanova V.V., Grigorova N.I., Bobkov E.N., Kirzhanov V.N., Sidoryuk O.V. Addiction Care in Russian Federaton in 2019–2020, an analytic review. Federal State Budgetary Institution “National Medical Research Center for Psychiatry and Narcology named after V.P. Serbsky” of the Ministry of Health of the Russian Federation. 2020 Mosocw (Aнaлитичecкиe oбзopы нapкoлoгичecкoй cлyжбы PФ• HHЦ Hapкoлoгии. . 2018. Available from: https://webmed.irkutsk.ru/doc/pdf/1405975657.pdf Kirzhanova V.V., Grigorova N.I., Bobkov E.N., Kirzhanov V.N., Sidoryuk O.V. Addiction Care in Russian Federaton in 2019–2020, an analytic review. Federal State Budgetary Institution “National Medical Research Center for Psychiatry and Narcology named after V.P. Serbsky” of the Ministry of Health of the Russian Federation. 2020 Mosocw (Aнaлитичecкиe oбзopы нapкoлoгичecкoй cлyжбы PФ• HHЦ Hapкoлoгии. . 2018. Available from: https://​webmed.​irkutsk.​ru/​doc/​pdf/​1405975657.​pdf
15.
Zurück zum Zitat Пoкpoвcкий BB, Улyмбeкoвa ГЭ, Пeтpaчкoв ИB. Opгaнизaция мeдицинcкoй пoмoщи пpи инфeкции, вызывaeмoй виpycoм иммyнoдeфицитa чeлoвeкa. OPГЗДPAB: Hoвocти Mнeния Oбyчeниe Becтник BШOУЗ. 2022;(2 (28)):108–30. Пoкpoвcкий BB, Улyмбeкoвa ГЭ, Пeтpaчкoв ИB. Opгaнизaция мeдицинcкoй пoмoщи пpи инфeкции, вызывaeмoй виpycoм иммyнoдeфицитa чeлoвeкa. OPГЗДPAB: Hoвocти Mнeния Oбyчeниe Becтник BШOУЗ. 2022;(2 (28)):108–30.
16.
Zurück zum Zitat World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017. World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017.
17.
Zurück zum Zitat Idrisov B, Lunze K, Cheng DM, Blokhina E, Gnatienko N, Quinn E, et al. Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia. Addict Sci Clin Pract. 2017;12(1):1–10.CrossRef Idrisov B, Lunze K, Cheng DM, Blokhina E, Gnatienko N, Quinn E, et al. Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia. Addict Sci Clin Pract. 2017;12(1):1–10.CrossRef
18.
Zurück zum Zitat Gnatienko N, Han SC, Krupitsky E, Blokhina E, Bridden C, Chaisson CE, et al. Linking Infectious and Narcology Care (LINC) in Russia: design, intervention and implementation protocol. Addict Sci Clin Pract. 2016;11(1):10.CrossRefPubMedPubMedCentral Gnatienko N, Han SC, Krupitsky E, Blokhina E, Bridden C, Chaisson CE, et al. Linking Infectious and Narcology Care (LINC) in Russia: design, intervention and implementation protocol. Addict Sci Clin Pract. 2016;11(1):10.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.CrossRef
21.
Zurück zum Zitat Kalichman SC, Catz S, Ramachandran B. Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. J Natl Med Assoc. 1999;91(8):439.PubMedPubMedCentral Kalichman SC, Catz S, Ramachandran B. Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. J Natl Med Assoc. 1999;91(8):439.PubMedPubMedCentral
22.
Zurück zum Zitat Zaragoza-Macias E, Cosco D, Nguyen ML, Del Rio C, Lennox J. Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population. AIDS Res Hum Retroviruses. 2010;26(2):133–8.CrossRefPubMedPubMedCentral Zaragoza-Macias E, Cosco D, Nguyen ML, Del Rio C, Lennox J. Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population. AIDS Res Hum Retroviruses. 2010;26(2):133–8.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Shacham E, Nurutdinova D, Onen N, Stamm K, Overton ET. The interplay of sociodemographic factors on virologic suppression among a US outpatient HIV clinic population. AIDS Patient Care STDS. 2010;24(4):229–35.CrossRefPubMedPubMedCentral Shacham E, Nurutdinova D, Onen N, Stamm K, Overton ET. The interplay of sociodemographic factors on virologic suppression among a US outpatient HIV clinic population. AIDS Patient Care STDS. 2010;24(4):229–35.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Simoni JM, Yard SS, Huh D. Prospective prediction of viral suppression and immune response nine months after ART initiation in Seattle. WA AIDS care. 2013;25(2):181–5.CrossRefPubMed Simoni JM, Yard SS, Huh D. Prospective prediction of viral suppression and immune response nine months after ART initiation in Seattle. WA AIDS care. 2013;25(2):181–5.CrossRefPubMed
25.
Zurück zum Zitat Burke M, Gong E, Jones K. Income Shocks and HIV in Africa. Econ J. 2015;125(585):1157–89.CrossRef Burke M, Gong E, Jones K. Income Shocks and HIV in Africa. Econ J. 2015;125(585):1157–89.CrossRef
26.
Zurück zum Zitat Gueler A, Schoeni-Affolter F, Moser A, Bertisch B, Bucher HC, Calmy A, et al. Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland. AIDS. 2015;29(2):231–8.CrossRefPubMed Gueler A, Schoeni-Affolter F, Moser A, Bertisch B, Bucher HC, Calmy A, et al. Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland. AIDS. 2015;29(2):231–8.CrossRefPubMed
Metadaten
Titel
Socioeconomic Status and CD4 Count Among People with HIV Who Inject Drugs in St. Petersburg, Russia
verfasst von
Bulat Idrisov
Jenna Van Draanen
Sara Lodi
Karsten Lunze
Simeon D. Kimmel
Emily Kate Quinn
Ve Truong
Elena Blokhina
Natalia Gnatienko
Evgeny Krupitsky
Jeffrey H. Samet
Emily C. Williams
Publikationsdatum
24.04.2024
Verlag
Springer US
Erschienen in
AIDS and Behavior
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-024-04316-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.